Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Dr. Arevitalize vs JRNYS

Dr. Arevitalize
Graded #225

Higher grade

vs+2.700000000000003
JRNYS
Graded #267

Lower grade

The verdict

Dr. Arevitalize takes it — 65.2/100 to 62.5/100.

Dr. Arevitalize grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Dr. Arevitalize (Dr.Arevitalize Health, Inc.) is a LegitScript-certified telehealth platform offering compounded GLP-1 weight-loss medication in both injectable and oral-capsule forms — semaglutide fr

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueJRNYS +6
39
45
Dose & formulationDr. Arevitalize +17
75
58
Clinical oversightJRNYS +13
71
84
Labs & monitoringDr. Arevitalize +17
88
71
FulfillmentDr. Arevitalize +7
72
65
Contract termsEven
55
55
Dr. Arevitalize · left barJRNYS · right bar

The numbers

MetricDr. ArevitalizeJRNYS
WeighScore65.2/10062.5/100
GradeCC
Scorecard rank#225#267
Semaglutide$319/mo (compounded)Not disclosed
Tirzepatide$359/mo (compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesInjection only
Dr. Arevitalize

Graded #225 · C

Strengths

  • Offers both injectable and oral-capsule compounded GLP-1 — a needle-free option many providers do not carry
  • Semaglutide from $269/mo and tirzepatide from $349/mo, in 1-, 3-, 6-, and 12-month bundles
  • LegitScript-certified; clinician-guided with lab/bloodwork analysis and personalized plans
  • Intro pricing on injectable semaglutide ($269, was $319) and oral semaglutide ($299, was $349)

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Compounding pharmacy partner and prescribing clinician are not named on the site
  • State availability is not published on the site
JRNYS

Graded #267 · C

Strengths

  • Branded, FDA-approved GLP-1s — Wegovy, Ozempic, Zepbound, Mounjaro and Saxenda — rather than compounded copies
  • The membership band is published before intake and is banded openly by level of coach support
  • Medical visits, daily monitoring and 1-on-1 coaching are included in the membership at every tier
  • Led by CMO Dr. Henry Legere (UC Berkeley, Columbia medicine, Harvard fellowship)
  • Members with commercial insurance may pay around $25 a month for the medication after any deductible

Where it loses points

  • The membership is overhead, not a medication price: it covers visits, monitoring and coaching, and the FAQ says medication pricing is confirmed only after a provider consultation
  • No self-pay drug price is published anywhere, so the cost of a month cannot be worked out before signing up
  • The best case depends on commercial insurance coverage; without it the medication cost is unknown
  • No compounded option is disclosed — the programme is brand-focused, and brand list prices are the dearest route to a GLP-1
  • The states it can prescribe in are not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard